Skip to main content
Fig. 4 | BMC Urology

Fig. 4

From: Skin rash following Administration of Apalutamide in Japanese patients with Advanced Prostate Cancer: an integrated analysis of the phase 3 SPARTAN and TITAN studies and a phase 1 open-label study

Fig. 4

Plasma-Exposure and Incidence of Rash: Pooled results of Japanese patients from SPARTAN and TITAN studies. a) Apalutamide, b) N-desmethyl apalutamide. Relationships between incidence of rash (by grade) and the plasma exposure (AUC0–24, ss) to apalutamide or N-desmethyl apalutamide were explored using boxplots

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us